Preventive effect of resistant starch on activated carbon-induced constipation in mice

Qian,Yu; Zhao,Xin; Kan,Jianquan

doi:10.3892/etm.2013.1096

Preventive effect of resistant starch on activated carbon-induced constipation in mice

Authors:
- Yu Qian
- Xin Zhao
- Jianquan Kan
View Affiliations

Affiliations: Department of Food Chemistry and Nutrition, Southwest University, Chongqing 400715, P.R. China, Department of Biological and Chemical Engineering, Chongqing University of Education, Chongqing 400067, P.R. China
Published online on: May 1, 2013 https://doi.org/10.3892/etm.2013.1096
Pages: 228-232

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to investigate the effects of resistant starch (RS) on activated carbon-induced constipation in ICR mice. ICR mice were fed on diet containing 15% RS of type RS2, RS3 or RS4 for 9 days. Gastrointestinal transit, defecation time and intestinal tissue histopathological sections, as well as motilin (MTL), gastrin (Gas), endothelin (ET), somatostatin (SS), acetylcholinesterase (AChE), substance P (SP) and vasoactive intestinal peptide (VIP) levels in serum were used to evaluate the preventive effects of RS on constipation. Bisacodyl, a laxative drug, was used as a positive control. The time to the first black stool defecation for normal, control, bisacodyl-treated (100 mg/kg, oral administration) and RS2-, RS3- and RS4-treated mice was 78, 208, 109, 181, 144 and 173 min, respectively. Following the consumption of RS2, RS3 and RS4 or the oral administration of bisacodyl (100 mg/kg), the gastrointestinal transit was reduced to 37.7, 52.1, 39.3 and 87.3%, respectively, of the transit in normal mice, respectively. Histopathological sections of intestinal tissue also underscored the protective effect of RS3. The serum levels of MTL, Gas, ET, AChE, SP and VIP were significantly increased and the serum levels of SS were reduced in the mice treated with RS compared with those in the untreated control mice (P<0.05). These results demonstrate that RS has preventive effects on mouse constipation and RS3 demonstrated the best functional activity.

View Figures

View References

1.	No authors listed. Carbohydrates in human nutrition. Report of a Joint FAO/WHO Expert Consultation. FAO Food Nutr Pap. 66:1–140. 1998.PubMed/NCBI
2.	Englyst HN, Kingman SM and Cummings JH: Classification and measurement of nutritionally important starch fractions. Eur J Clin Nutr. 46(Suppl 2): S33–S50. 1992.PubMed/NCBI
3.	Gordon DT, Topp K, Shi YC, Zallie J and Jeffcoat R: Resistant starch: physical and physiological properties. New Technologies For Healthy Foods & Nutraceuticals. Yalpani M: ATL Press Inc; Shrewsbury, MA: pp. 157–178. 1997
4.	McIntyre A, Albert V, Folino M, Muir J, Gibson PR and Young GP: Resistant starch from corn behaves like soluble and not insoluble fibre in a rat model of large bowel cancer. Proc Nutr Soc Aust. 18:611994.
5.	Younes C, Levrat MA, Demigné C and Rémésy C: Resistant starch is more effective than cholestyramine as a lipid-lowering agent in the rat. Lipids. 30:847–853. 1995. View Article : Google Scholar : PubMed/NCBI
6.	Macfarlane GT and Englyst HN: Starch utilization by the human large intestinal microflora. J Appl Microbiol. 60:195–201. 1986.PubMed/NCBI
7.	Baghurst PA, Baghurst KI and Record SJ: Dietary fiber, non-starch polysaccharides and resistant starch - a review. Food Australia. 48:S1–S36. 1996.
8.	Ueki A and Otsuka M: Life style risks of Parkinson’s disease: Association between decreased water intake and constipation. J Neurol. 251(Suppl 7): S18–S23. 2004.
9.	Wexner SD, Beck DE, Baron TH, Fanelli RD, Hyman N, Shen B and Wasco KE: A consensus document on bowel preparation before colonoscopy: prepared by a task force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Gastrointest Endosc. 63:894–909. 2006.
10.	Farrugia G, Miller SM, Rich A, Liu X, Maines MD, Rae JL and Szurszewski JH: Distribution of heme oxygenase and effects of active carbon monoxide in canine jejunum. Am J Physiol. 274:G350–G358. 1998.PubMed/NCBI
11.	Farrugia G, Lei S, Lin X, Miller SM, Nath KA, Ferris CD, Levitt M and Szurszewski JH: A major role for carbon monoxide as an endogenous hyperpolarizing factor in the gastrointestinal tract. Proc Natl Acad Sci USA. 100:8567–8570. 2003. View Article : Google Scholar : PubMed/NCBI
12.	Miller SM, Reed D, Sarr MG, Farrugia G and Szurszewski JH: Haem oxygenase in enteric nervous system of human stomach and jejunum and co-localization with nitric oxide synthase. Neurogastroenterol Motil. 13:121–131. 2001. View Article : Google Scholar : PubMed/NCBI
13.	Xue L, Farrugia G, Miller SM, Ferris CD, Snyder SH and Szurszewski JH: Carbon monoxide and nitric oxide as coneurotransmitters in the enteric nervous system: evidence from genomic deletion of biosynthetic enzymes. Proc Natl Acad Sci USA. 97:1851–1855. 2000. View Article : Google Scholar : PubMed/NCBI
14.	Battish R, Cao GY, Lynn RB, Chakder S and Rattan S: Heme oxygenase-2 distribution in anorectum: colocalization with neuronal nitric oxide synthase. Am J Physiol Gastrointest Liver Physiol. 278:G148–G155. 2000.PubMed/NCBI
15.	Dolk A, Brodén G, Holmström B, Johansson C and Schultzberg M: Slow transit chronic constipation (Arbuthnot Lane’s disease). An immunohistochemical study of neuropeptide-containing nerves in resected specimens from the large bowel. Int J Colorectal Dis. 5:181–187. 1990.
16.	Walia R, Mahajan L and Steffen R: Recent advances in chronic constipation. Curr Opin Pediatr. 21:661–666. 2009. View Article : Google Scholar
17.	Emmanuel AV, Tack J, Quigley EM and Talley NJ: Pharmacological management of constipation. Neurogastroenterol Motil. 21(Suppl 2): S41–S54. 2009. View Article : Google Scholar
18.	Lubowski DZ, Chen FC, Kennedy ML and King DW: Results of colectomy for severe slow transit constipation. Dis Colon Rectum. 39:23–29. 1996. View Article : Google Scholar
19.	Ludvigsson JF, Montgomery SM, Ekbom A, Brandt L and Granath F: Small-intestinal histopathology and mortality risk in celiac disease. JAMA. 302:1171–1178. 2009. View Article : Google Scholar : PubMed/NCBI
20.	Zhao Y, Zhang B, Qin G, Wang T, Wang J and Han R: Distribution of glycinin in the gastrointestinal tissue of pigs at different growth stages. Food Agric Immunol. 1–8. 2012.
21.	Palay SL and Karlin LJ: An electron microscopic study of the intestinal villus II. The pathway of fat absorption. J Biophys Biochem Cytol. 5:373–384. 1959. View Article : Google Scholar : PubMed/NCBI
22.	Sjölund K, Ekman R, Akre F and Lindner P: Motilin in chronic idiopathic constipation. Scand J Gastroenterol. 21:914–918. 1986.
23.	el-Salhy M and Norrgård O: Colonic neuroendocrine peptide levels in patients with chronic idiopathic slow transit constipation. Ups J Med Sci. 103:223–230. 1998. View Article : Google Scholar : PubMed/NCBI
24.	Silkoff P, Karmeli F, Goldin E, Ewenson A, Gilon C, Chorev M, Laufer R, Selinger Z and Rachmilewitz D: Effect of substance P on rat gastrointestinal transit. Digest Dis Sci. 33:74–77. 1988. View Article : Google Scholar : PubMed/NCBI
25.	Feighner SD, Tan CP, McKee KK, Palyha OC, Hreniuk DL, Pong SS, Austin CP, Figueroa D, MacNeil D, Cascieri MA, Nargund R, Bakshi R, Abramovitz M, Stocco R, Kargman S, O’Neill G, Van Der Ploeg LH, Evans J, Patchett AA, Smith RG and Howard AD: Receptor for motilin identified in the human gastrointestinal system. Science. 284:2184–2188. 1999. View Article : Google Scholar : PubMed/NCBI
26.	Preston DM, Adrian TE, Christofides ND, Lennard-Jones JE and Bloom SR: Positive correlation between symptoms and circulating motilin, pancreatic polypeptide and gastrin concentrations in functional bowel disorders. Gut. 26:1059–1064. 1985. View Article : Google Scholar
27.	Soudah HC, Hasler WL and Owyang C: Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med. 325:1461–1467. 1991. View Article : Google Scholar : PubMed/NCBI
28.	Furchgott RF and Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:373–376. 1980. View Article : Google Scholar : PubMed/NCBI
29.	Tzavella K, Riepl RL, Klauser AG, Voderholzer WA, Schindlbeck NE and Müller-Lissner SA: Decreased substance P levels in rectal biopsies from patients with slow transit constipation. Eur J Gastroen Hepat. 8:1207–1211. 1996. View Article : Google Scholar : PubMed/NCBI
30.	Milner P, Crowe R, Kamm MA, Lennard-Jones JE and Burnstock G: Vasoactive intestinal polypeptide levels in sigmoid colon in idiopathic constipation and diverticular disease. Gastroenterology. 99:666–675. 1990.PubMed/NCBI
31.	Roy CC, Kien CL, Bouthillier L and Levy E: Short-chain fatty acids: ready for prime time? Nutr Clin Pract. 21:351–366. 2006. View Article : Google Scholar : PubMed/NCBI